Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q21011225> ?p ?o }
Showing triples 1 to 26 of
26
with 100 triples per page.
- Q21011225 subject Q16811554.
- Q21011225 subject Q8844484.
- Q21011225 subject Q9052323.
- Q21011225 abstract "Efinaconazole (trade names Jublia and Clenafin) is a triazole antifungal. It is approved for use in Canada and the USA as a 10% topical solution for the treatment of onychomycosis (fungal infection of the nail). Efinaconazole acts as a 14α-demethylase inhibitor.In two clinical trials 17.8% and 15.2% of patients using Efinaconazole were cured, compared to 3.3% and 5.5% of patients using a placebo.Efinaconazole is not especially effective, but it is currently the best topical treatment available, with cure rates two or three times better than the next best topical treatment, ciclopirox. It is considered a reasonable options for patients with mild cases, or patients who can not take oral treatment.In 2014, the U.S. Food and Drug Administration (FDA) approved the New Drug Application (NDA) for Jublia, the "first topical triazole approved for the treatment of onychomycosis of the toenails." According to Valeant Pharmaceuticals International Inc CEO J. Michael Pearson they acquired Jublia through their purchase of Dow Pharmaceutical Sciences in 2008.".
- Q21011225 thumbnail Efinaconazole.svg?width=300.
- Q21011225 wikiPageWikiLink Q1368197.
- Q21011225 wikiPageWikiLink Q16811554.
- Q21011225 wikiPageWikiLink Q1700871.
- Q21011225 wikiPageWikiLink Q1805541.
- Q21011225 wikiPageWikiLink Q204711.
- Q21011225 wikiPageWikiLink Q36864.
- Q21011225 wikiPageWikiLink Q419468.
- Q21011225 wikiPageWikiLink Q427492.
- Q21011225 wikiPageWikiLink Q578726.
- Q21011225 wikiPageWikiLink Q6106540.
- Q21011225 wikiPageWikiLink Q8844484.
- Q21011225 wikiPageWikiLink Q9052323.
- Q21011225 wikiPageWikiLink Q917620.
- Q21011225 type ChemicalSubstance.
- Q21011225 type Drug.
- Q21011225 type ChemicalObject.
- Q21011225 type Thing.
- Q21011225 type Q8386.
- Q21011225 comment "Efinaconazole (trade names Jublia and Clenafin) is a triazole antifungal. It is approved for use in Canada and the USA as a 10% topical solution for the treatment of onychomycosis (fungal infection of the nail).".
- Q21011225 label "Efinaconazole".
- Q21011225 depiction Efinaconazole.svg.